BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 15794099)

  • 21. Effects of neuropeptides of the secretin/VIP/PACAP family on cyclic AMP formation in the chick hypothalamus and cerebral cortex.
    Nowak JZ; Kuba K; Zawilska JB
    Pol J Pharmacol; 2000; 52(6):467-71. PubMed ID: 11334241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-acting analogue of vasoactive intestinal peptide, [R15, 20, 21, L17]-VIP-GRR (IK312532), protects rat alveolar L2 cells from the cytotoxicity of cigarette smoke.
    Onoue S; Endo K; Ohmori Y; Yamada S; Kimura R; Yajima T; Kashimoto K
    Regul Pept; 2004 Dec; 123(1-3):193-9. PubMed ID: 15518912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors: distribution and involvement in the secretion of Podarcis sicula adrenal gland.
    Valiante S; Prisco M; Sciarrillo R; De Falco M; Capaldo A; Gay F; Andreuccetti P; Laforgia V; Varano L
    J Endocrinol; 2008 Feb; 196(2):291-303. PubMed ID: 18252952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intestinal adaptation in atrophic rat ileum is accompanied by supersensitivity to vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide and nitric oxide.
    Ekelund M; Ekblad E
    Scand J Gastroenterol; 2001 Mar; 36(3):251-7. PubMed ID: 11305511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates exocrine pancreas in conscious preruminating calves.
    Zabielski R; Onaga T; Mineo H; Okine E; Kato S
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1994 Sep; 109(1):93-9. PubMed ID: 7881813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
    Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R
    J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain.
    Gressens P; Marret S; Hill JM; Brenneman DE; Gozes I; Fridkin M; Evrard P
    J Clin Invest; 1997 Jul; 100(2):390-7. PubMed ID: 9218516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of VIP-induced neuroprotection against neonatal excitotoxicity.
    Rangon CM; Dicou E; Goursaud S; Mounien L; Jégou S; Janet T; Muller JM; Lelièvre V; Gressens P
    Ann N Y Acad Sci; 2006 Jul; 1070():512-7. PubMed ID: 16888217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuritogenesis induced by vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide, and peptide histidine methionine in SH-SY5y cells is associated with regulated expression of cytoskeleton mRNAs and proteins.
    Héraud C; Hilairet S; Muller JM; Leterrier JF; Chadéneau C
    J Neurosci Res; 2004 Feb; 75(3):320-9. PubMed ID: 14743445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of mRNAs for PACAP and its receptor in human neuroblastomas and their relationship to catecholamine synthesis.
    Isobe K; Kaneko M; Kaneko S; Nissato S; Nanmoku T; Takekoshi K; Okuda Y; Kawakami Y
    Regul Pept; 2004 Dec; 123(1-3):29-32. PubMed ID: 15518890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PACAP, VIP, and PHI: effects on AC-, PLC-, and PLD-driven signaling systems in the primary glial cell cultures.
    Dejda A; Jozwiak-Bebenista M; Nowak JZ
    Ann N Y Acad Sci; 2006 Jul; 1070():220-5. PubMed ID: 16888170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anorexigenic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: feeding-induced changes in the expression of mRNAs for PACAP and its receptors in the brain, and locomotor response to central injection.
    Matsuda K; Maruyama K; Miura T; Uchiyama M; Shioda S
    Neurosci Lett; 2005 Sep; 386(1):9-13. PubMed ID: 15975713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) activate protein kinase C in chick cerebral cortex.
    Nowak JZ; Dejda A; Zawilska JB
    Pol J Pharmacol; 2001; 53(6):695-9. PubMed ID: 11985349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PACAP and VIP prevent apoptosis in schwannoma cells.
    Castorina A; Tiralongo A; Giunta S; Carnazza ML; Rasi G; D'Agata V
    Brain Res; 2008 Nov; 1241():29-35. PubMed ID: 18835258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The neuropeptides vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) modulate several biochemical pathways in human leukemic myeloid cells.
    Hayez N; Harfi I; Lema-Kisoka R; Svoboda M; Corazza F; Sariban E
    J Neuroimmunol; 2004 Apr; 149(1-2):167-81. PubMed ID: 15020077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alfa 1 adrenergic potentiation of progesterone accumulation stimulated by vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) in cultured rat granulosa cells.
    Wasilewska-Dziubiñska E; Borowiec M; Chmielowska M; Woliñska-Witort E; Baranowska B
    Neuro Endocrinol Lett; 2002 Apr; 23(2):141-8. PubMed ID: 12011800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of pituitary adenylate cyclase activating polypeptide in a rat model of traumatic brain injury.
    Farkas O; Tamás A; Zsombok A; Reglodi D; Pál J; Büki A; Lengvári I; Povlishock JT; Dóczi T
    Regul Pept; 2004 Dec; 123(1-3):69-75. PubMed ID: 15518895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pituitary adenylate cyclase-activating polypeptide induces translocation of its G-protein-coupled receptor into caveolin-enriched membrane microdomains, leading to enhanced cyclic AMP generation and neurite outgrowth in PC12 cells.
    Zhang W; Duan W; Cheung NS; Huang Z; Shao K; Li QT
    J Neurochem; 2007 Nov; 103(3):1157-67. PubMed ID: 17680996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroprotective potential of three neuropeptides PACAP, VIP and PHI.
    Dejda A; Sokołowska P; Nowak JZ
    Pharmacol Rep; 2005; 57(3):307-20. PubMed ID: 15985713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Central administration of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide differentially regulates energy metabolism in chicks.
    Tachibana T; Oikawa D; Adachi N; Boswell T; Furuse M
    Comp Biochem Physiol A Mol Integr Physiol; 2007 May; 147(1):156-64. PubMed ID: 17291802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.